System Transmission

Top Signal

100#1 JOB

Activity

2171Ripe

+912 today

System

Livenow

Terminal Asset View

stockNASDAQ

AKBA

$1.46+4.29%

Akebia Therapeutics Inc

Ripening

Official Site

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

58Ripening

Live Analysis Active

Synchronizing Data Stream

Establishing multi-vendor link for AKBA

Pipeline Initializing...

System Progress0%

Low Latency Link

Encrypted Port

Company Mission

Akebia Therapeutics develops and sells medications for people with kidney diseases, particularly anemia related to chronic kidney disease. Their drugs help patients manage their condition by improving red blood cell production. The company makes money by selling these medications to healthcare providers and through partnerships with larger pharmaceutical companies that help distribute their treatments.

AKB

Industry Context

Akebia operates in the biotechnology industry, which focuses on developing new medical treatments. This sector experiences significant price movements when companies announce clinical trial results or receive regulatory approvals for their drugs. Companies in this space often trade based on expectations about their research pipeline rather than current profits.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

69Matrix

Market Momentum

60.9— Holding Steady

Trend Strength

75— Active Setup

Momentum Engine

Accelerating

Velocity Score

Accelerating

StaticOptimal FlowMax Vel

Trading Activity

1.1x— Normal Volume

Today's Change

4.29%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

EMA Distance-0

Price is overextended from the 20-day trend lead.

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing AKBA across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 09:14 PM UTC

As-of 03-14-2026 20:59 UTC

Develops drugs to treat kidney disease and anemia, earning money from drug sales and partnerships with larger pharmaceutical companies.

Weekly price swings are getting smaller, suggesting the Stock may be preparing for a bigger move soon showing consolidation pattern.

Biotech sector volatility often increases during drug trial results, which could impact this company's Stock movement.

Educational only. Not investment advice.

Precision Intelligence Model

Live Terminal Stream

Loading chart...